WO1999053037A2 - Sequences optimisees de nucleosides codant pour des hydrolases organophosphorees, et leurs methodes d'utilisation - Google Patents
Sequences optimisees de nucleosides codant pour des hydrolases organophosphorees, et leurs methodes d'utilisation Download PDFInfo
- Publication number
- WO1999053037A2 WO1999053037A2 PCT/US1999/008202 US9908202W WO9953037A2 WO 1999053037 A2 WO1999053037 A2 WO 1999053037A2 US 9908202 W US9908202 W US 9908202W WO 9953037 A2 WO9953037 A2 WO 9953037A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- sequence
- expression
- nucleotide sequence
- gene
- Prior art date
Links
- 239000002773 nucleotide Substances 0.000 title claims abstract description 27
- 125000003729 nucleotide group Chemical group 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims description 48
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 97
- 230000014509 gene expression Effects 0.000 claims abstract description 55
- 239000013598 vector Substances 0.000 claims abstract description 24
- 230000009261 transgenic effect Effects 0.000 claims abstract description 19
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 13
- 239000002581 neurotoxin Substances 0.000 claims abstract description 9
- 231100000618 neurotoxin Toxicity 0.000 claims abstract description 9
- 238000001784 detoxification Methods 0.000 claims abstract description 6
- 230000007613 environmental effect Effects 0.000 claims abstract description 5
- 238000011065 in-situ storage Methods 0.000 claims abstract description 4
- 101710138657 Neurotoxin Proteins 0.000 claims abstract description 3
- 230000001939 inductive effect Effects 0.000 claims description 20
- 239000013612 plasmid Substances 0.000 claims description 20
- 102000004157 Hydrolases Human genes 0.000 claims description 16
- 108090000604 Hydrolases Proteins 0.000 claims description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
- 230000001105 regulatory effect Effects 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 239000002689 soil Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- 150000007523 nucleic acids Chemical group 0.000 claims description 2
- 238000010276 construction Methods 0.000 claims 1
- 238000000855 fermentation Methods 0.000 claims 1
- 230000004151 fermentation Effects 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 230000009466 transformation Effects 0.000 abstract description 28
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 102000004190 Enzymes Human genes 0.000 abstract description 8
- 108090000790 Enzymes Proteins 0.000 abstract description 8
- 241000588724 Escherichia coli Species 0.000 abstract description 7
- 241000894006 Bacteria Species 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 description 182
- 210000004027 cell Anatomy 0.000 description 39
- 108020004414 DNA Proteins 0.000 description 33
- 210000001519 tissue Anatomy 0.000 description 33
- 240000008042 Zea mays Species 0.000 description 21
- 230000008929 regeneration Effects 0.000 description 18
- 238000011069 regeneration method Methods 0.000 description 18
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 16
- 150000001413 amino acids Chemical class 0.000 description 16
- 101150027424 oph gene Proteins 0.000 description 16
- 210000001938 protoplast Anatomy 0.000 description 16
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 13
- 235000009973 maize Nutrition 0.000 description 13
- 238000012546 transfer Methods 0.000 description 13
- 239000012634 fragment Substances 0.000 description 12
- 206010020649 Hyperkeratosis Diseases 0.000 description 11
- 108091034117 Oligonucleotide Proteins 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 10
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 9
- 108091026890 Coding region Proteins 0.000 description 9
- 244000061176 Nicotiana tabacum Species 0.000 description 9
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 9
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 239000000411 inducer Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 108020004999 messenger RNA Proteins 0.000 description 9
- 108090000754 Phosphoric Triester Hydrolases Proteins 0.000 description 8
- 102000004203 Phosphoric Triester Hydrolases Human genes 0.000 description 8
- 238000010367 cloning Methods 0.000 description 8
- 210000000056 organ Anatomy 0.000 description 8
- 239000000575 pesticide Substances 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 241000589158 Agrobacterium Species 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 241000589539 Brevundimonas diminuta Species 0.000 description 6
- 241000701489 Cauliflower mosaic virus Species 0.000 description 6
- 238000004520 electroporation Methods 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 5
- 244000025272 Persea americana Species 0.000 description 5
- 235000008673 Persea americana Nutrition 0.000 description 5
- 108020004511 Recombinant DNA Proteins 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 240000003768 Solanum lycopersicum Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 4
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 4
- 235000006008 Brassica napus var napus Nutrition 0.000 description 4
- 240000000385 Brassica napus var. napus Species 0.000 description 4
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 4
- 241000209510 Liliopsida Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 241000219000 Populus Species 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 239000013043 chemical agent Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000002939 deleterious effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000002917 insecticide Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 108020004705 Codon Proteins 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000299507 Gossypium hirsutum Species 0.000 description 3
- 244000020551 Helianthus annuus Species 0.000 description 3
- 235000003222 Helianthus annuus Nutrition 0.000 description 3
- 240000004658 Medicago sativa Species 0.000 description 3
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000010353 genetic engineering Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 230000008488 polyadenylation Effects 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 230000005070 ripening Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000701447 unidentified baculovirus Species 0.000 description 3
- 230000001018 virulence Effects 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- 229930192334 Auxin Natural products 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- 108700010070 Codon Usage Proteins 0.000 description 2
- 240000008067 Cucumis sativus Species 0.000 description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 2
- 241000450599 DNA viruses Species 0.000 description 2
- GRPRVIYRYGLIJU-UHFFFAOYSA-N Demeton-S Chemical compound CCOP(=O)(OCC)SCCSCC GRPRVIYRYGLIJU-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 239000005949 Malathion Substances 0.000 description 2
- 101710202365 Napin Proteins 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 101710163504 Phaseolin Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 101000611441 Solanum lycopersicum Pathogenesis-related leaf protein 6 Proteins 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000002363 auxin Substances 0.000 description 2
- RQVGAIADHNPSME-UHFFFAOYSA-N azinphos-ethyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OCC)OCC)N=NC2=C1 RQVGAIADHNPSME-UHFFFAOYSA-N 0.000 description 2
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 2
- 230000036983 biotransformation Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000004062 cytokinin Substances 0.000 description 2
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 description 2
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 2
- 108010027293 diisopropyl-fluorophosphatase Proteins 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 241001233957 eudicotyledons Species 0.000 description 2
- 230000004345 fruit ripening Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- -1 lie Chemical compound 0.000 description 2
- 229960000453 malathion Drugs 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 2
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 2
- 230000009894 physiological stress Effects 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000013605 shuttle vector Substances 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000007970 thio esters Chemical class 0.000 description 2
- 239000013603 viral vector Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BRZYSWJRSDMWLG-DJWUNRQOSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-DJWUNRQOSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 102100033639 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- 101710146995 Acyl carrier protein Proteins 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 241000024188 Andala Species 0.000 description 1
- 108010008184 Aryldialkylphosphatase Proteins 0.000 description 1
- 102000006996 Aryldialkylphosphatase Human genes 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 241000195585 Chlamydomonas Species 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- YRMLFORXOOIJDR-UHFFFAOYSA-N Dichlormid Chemical compound ClC(Cl)C(=O)N(CC=C)CC=C YRMLFORXOOIJDR-UHFFFAOYSA-N 0.000 description 1
- 206010013142 Disinhibition Diseases 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 101150062179 II gene Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- 241001599018 Melanogaster Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108091092740 Organellar DNA Proteins 0.000 description 1
- 101710198366 Parathion hydrolase Proteins 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 240000000697 Pinguicula vulgaris Species 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 244000081426 Ranunculus ficaria Species 0.000 description 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061457 Solanum nigrum Species 0.000 description 1
- 235000002594 Solanum nigrum Nutrition 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 244000042324 Trifolium repens Species 0.000 description 1
- 235000013540 Trifolium repens var repens Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 108010009043 arylesterase Proteins 0.000 description 1
- 102000028848 arylesterase Human genes 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
- MKQSWTQPLLCSOB-UHFFFAOYSA-N benzyl 2-chloro-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate Chemical compound N1=C(Cl)SC(C(=O)OCC=2C=CC=CC=2)=C1C(F)(F)F MKQSWTQPLLCSOB-UHFFFAOYSA-N 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003413 degradative effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- JSYGRUBHOCKMGQ-UHFFFAOYSA-N dichloramine Chemical compound ClNCl JSYGRUBHOCKMGQ-UHFFFAOYSA-N 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 108010087711 leukotriene-C4 synthase Proteins 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 101150070593 lox gene Proteins 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 108091005573 modified proteins Proteins 0.000 description 1
- 102000035118 modified proteins Human genes 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 210000004789 organ system Anatomy 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000008121 plant development Effects 0.000 description 1
- 230000037039 plant physiology Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000012340 reverse transcriptase PCR Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 231100000701 toxic element Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 231100000588 tumorigenic Toxicity 0.000 description 1
- 230000000381 tumorigenic effect Effects 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
Definitions
- Synthetic organophosphorous neurotoxins are used extensively as agricultural and domestic pesticides, including insecticides, fungicides, and herbicides.
- Naturally occurring bacterial isolates capable of metabolizing this class of compounds have received considerable attention since they provide the possibility of both environmental and in situ detoxification.
- Pseudomonas putida MG, Pseudomonas diminuta, and Fla ⁇ obacterium, s.pp. have been shown to possess the ability to degrade an extremely broad spectrum of organophosphorous phosphotriesters as well as thiol esters.
- Organophosphorous hydrolase is a broad spectrum OP hydrolase that is capable of detoxifying organophosphorous neurotoxins by creating various phosphoryl bonds (P-O, P-F, P-CN, and P-S) between the phosphorous center and varying electrophilic leaving groups.
- This enzyme is often identified by more limited descriptors such as phosphotriesterase, DFPase, parathion hydrolase, parathion aryl esterase, or paraoxonase as well as being called a somanase or sarinase.
- the hydrolytic reaction rates with several phosphotriesterases appears to be limited by diffusion to the active center of the enzyme. (Caldwell et al., "Limits of Diffusion in the Hydrolysis of Substrates of the Phosphotriesterase From Pseudomonas diminuta 1 ', Biochemistry 30, 7438-7444 (1991)).
- This broad spectrum hydrolase is the only enzyme which has been shown to be able to hydrolyze the P-S bond of various phosphorothioate pesticides.
- the toxicity of hydrolyzed products has been shown to be significantly reduced as indicated by the loss of inhibition of acetyl cholinesterase activity and by decreased neurotoxic response in animals. (Kolakowski, et al., Biocatolisis and Biotransformation, Vol. 15, 297-312 (1997)).
- OP-thioate insecticides acephate, azinophos-ethyl, demeton-S, malathion and phosalone have been shown to be hydrolyzed by OPH.
- the hydrolysis of these pesticides has a first order dependency on the amount of enzyme used and the reaction time.
- the enzyme hydrolyzed acephate, azinophos-ethyl, demeton-S and phosalone at relatively fast velocities with reaction rates which are thousands of times greater than that which occurs during strong alkaline hydrolysis.
- the enzyme possessed poor capability for a malathion hydrolysis, although still significantly better than non-enzymatic hydrolysis under similar conditions.
- the thioesters (P-S bond esters) hydrolysis was much slower in general. (See Kolakowski, et al., Biokatolisis and Biotransformation, Vol., 297-312 (1997)).
- the present invention relates to the plant expression of OPH as well as the creation of a synthetic OPH nucleotide sequence which can be expressed in plant systems or yeast systems utilizing appropriate leader sequences whereby the expression level of OPH is greatly increased over that of E. coli or baculovirus systems.
- the present invention relates not only to the creation of the optimized OPH coding sequence, but also to transformation, expression of the same, and useof the recombinant protein in the hydrolysis of a variety of organophosphorous neurotoxins such as those in many widely used agricultural and domestic pesticides.
- the present invention is directed to a nucleotide sequence which encodes OPH and its expression in plant systems.
- the present invention is directed to a nucleotide sequence which encodes an optimized OPH gene preferrably with a host specific leader sequence.
- the present invention is further directed to expression constructs, vectors and transgenic plants which contain these OPH nucleotide sequences.
- the invention is directed to the expression of OPH in plant or yeast cells.
- the present invention is also directed to methods for using transgenic plants which express this OPH to detoxify environments which are contaminated with insecticides and other neurotoxins. More specifically, the present invention is directed to transgenic plants which are capable of expressing OPH at levels greater than that of the typical 10-15 mg/1 of E. coli or baculovirus.
- OPH nucleotide sequence of the present invention can be utilized in conjunction with a wide variety of host organisms including plants, bacteria and yeast. It should also be understood that trivial modifications to the OPH gene of this invention are encompassed in this invention. Further, while it is to be understood that the expression of the OPH of the present invention can be utilized either as present in the transgenic plants or harvested therefrom to hydrolyze neurotoxins such as pesticides, this expressed OPH gene can further be utilized to hydrolyze other chemical agents or compounds containing P-O, P-S, P-CN, and P-S bonds. BRIEF DESCRIPTION OF THE FIGURES
- Fig. 1 is a schematic of optimized OPH nucleotide sequence showing the restriction sites used in the synthesis of the gene.
- Fig. 2 is an optimized nucleotide sequence encoding OPH gene (SEQ ID NO:3).
- Fig. 3A and 3B are a nucleotide sequence which encodes plant leader sequence (SEQ ID NO:7).
- Fig. 4A and 4B are a nucleotide sequence which encodes OPH and which also contains a plant leader sequence (SEQ ID NO:5).
- the present invention includes novel nucleotide sequences which are optimized to encode an organophosphorous hydrolase protein.
- An expression construct comprising this sequence and regulatory elements for OPH expression in a host organism is also provided.
- the present invention also includes plants, seeds, and plant tissue capable of expressing the novel nucleotide sequence.
- Coding DNA Sequence A DNA sequence from which the information for making a peptide molecule, mRNA, or tRNA are transcribed.
- a DNA sequence may be a gene, combination of genes, or a gene fragment.
- Gene A chromosomal region which is responsible for a cellular product.
- Microorganism A member of one of the following classes; bacteria, fungi, protozoa or viruses.
- Plant Tissue Any tissue of a plant in plant or in culture. This term includes, but is not limited to, whole plants, plant cells, plant organs, plant seeds, embryos, pollen, silk, tassel, leaf, root, protoplasts, callus, cell cultures and any other group of plant cells organized into structural and/or functional units. The use of this term in conjunction with, or in the absence of, any specific type of plant tissue as listed above or otherwise embraced by this definition is not intended to be exclusive of any other type of plant tissue.
- Plant Transformation Vector A plant, bacterial or viral vector that is capable of transforming plant tissue such that following transformation the plant tissue contains the DNA to be introduced by the vector in the plant tissues.
- Substantial Sequence Homology Substantial functional and/or structural equivalents between sequences of nucleotides or amino acids. Functional and/or Structural Differences between sequences having substantial sequence homology will be diminimous.
- Synthetic Gene A DNA sequence that exists in total or in part through manufacture by manufacture in vitro.
- Transgenic Plant a plant which contains and expresses DNA that was not pre-existing in the plant, either at all or in the post-transformation quantity, prior to the introduction of the DNA into the plant.
- Organophosphorous hydrolase protein as used herein this term shall mean any protein or protein fragment which maintains the functional properties of OPH as determined by the assays described in Daie et al., "Characterization of Organophosphorous Hydrolases and the Genetic Manipulation of the Phosphotriesterase from Pseudomonas diminuta", Chemical-Biological Interactions, 87, 55-68 (1993), and Caldwell et al., "Limits of Diffusion in the Hydrolysis of Substrates of the Phosphotriesterase From Pseudomonas diminuta", Biochemistry 30, 7438-7444 (1991).
- this will be an amino acid with at least 30%-50% homology with at least one form of the protein as disclosed herein. 80% homology is preferred and 90% homology is most preferred especially including conservative substitutions.
- Homology is calculated by standard methods which involve aligning two sequences to be compared so that the maximum matching occurs, and calculating the percentage of matches. Substantially equivalent substances to these include those wherein one or more of the residues of the native sequence is deleted, substituted for, or inserted by a different amino acid or acids.
- Preferred substitutions are those which are conservative, i.e., wherein a residue is replaced by another of the same general type.
- naturally occurring amino acids can be sub classified as acidic, basic, neutral and polar, or neutral and nonpolar.
- peptides differing from the native OPH sequence contain substitutions which are from the same group as that of the amio acid replaced.
- the basic amino acids Lys and Arg are interchangeable; the acidic amino acids aspartic and glutamic are interchangeable; the neutral polar amino acids Ser, Thr, Cys, Gin, and Asn are interchangeable; the nonpolar aliphatic acids Gly, Ala, Val, lie, and Leu are conservative with respect to each other (but because of size, Gly and Ala are more closely related and Val, lie and Leu are more closely related), and the aromatic amino acids Phe, Trp, and Tyr are interchangeable.
- proline is a non-olar neutral amino acid, it represents difficulties because of its effects on conformation, and substitutions by or for proline are not preferred, except when the same or similar conformational results can be obtained.
- Polar amino acids which represent conservative changes include Ser, Thr, Gin, Asn; and to a lesser extent, Met.
- Ala, Gly, and Ser seem to be interchangeable, and Cys additionally fits into this group, or may be classified with the polar neutral amino acids. In general, whatever substitutions are made are such that the functional properties of the intact proteinaceous molecule is retained and ancillary properties, such as non-toxicity are not substantially disturbed as described earlier.
- conditions of high stringency shall mean nucleotide hybridization conditions equivalent to the following: 42°C in a buffer containing 50% formamide, 1M sodium chloride, 1% SDS, 10% dextran sulfate, 100 ⁇ g/ml denatured salmon sperm, or those described in Reppert, S.M. et al. (1994) Neuron 13:1177-1185. Optimized OPH Gene
- Codons were chosen so that deleterious mRNA signals would be eliminated in the DNA coding sequence.
- convenient restriction enzyme cites were added to facilitate downstream cloning.
- the optimized DNA coding sequence was divided into convenient cloning lengths and then each of these lengths were further subdivided into oligonucleotide s of approximately 50 bases in length with 10 base overhangs. Oligonucleotides corresponding to both the sense and antisense strand were synthesized and 5' phosphorylated. The oligonucleotides were then annealed and ligated. Following ligation, varying dilutions were subjected to PCR using primers specific to the 5' and 3' ends.
- PCR product was analyzed using poly acrylamide gels, and DNA of the proper expected lengths was extracted from the gel and the DNA eluted from the extracted gel material.
- the DNA was cloned into a pCR 2.1 TOPO(Invitrogen) plasmid as per the manufacturer's instructions. Transformed colonies containing the PCR insert were grown overnight and the plasmid DNA purified. The plasmid DNA was then analyzed for the correct PCR insert as per standard protocols known to those of skill in the art. The inserts were sequenced to verify that the correct sequence was created and the optimized gene was assembled properly using standard protocols known to those of skill in the art. Appropriate Leader Sequence
- an appropriate leader sequence or subcellular localization signal is preferably integrated onto the OPH encoding nucleotide sequence gene.
- a plant leader sequence will ensure high expression in plants while a yeast leader sequence will express high levels of OPH expression in yeast.
- the OPH gene containing the appropriate leader can be cloned into the standard expression cassette for that host to ensure high expression in that organism.
- a 5' fragment can be assembled to contain a plant leader sequence to ensure high expression in plants.
- the OPH gene containing the plant leader may be cloned into a standard plant upon expression cassette to ensure high expression in plants. Transformation techniques
- a nucleotide acid sequence of interest is isolated or synthesized, it is included into an expression cassette which typically comprises a transcription unit of a promoter operably linked to the nucleotide sequence which is functional in a plant cell and a termination or polyadenylation signal.
- This expression cassette typically forms part of a plant transformation vector.
- This plant transformation vector will also contain the appropriate regulatory sequences in addition to the gene of interest.
- the vector DNA facilitates manipulation of the gene in the host cell, such as E. coli. or yeast, prior to plant transformation.
- the host vector-cell can act as a vehicle to transfer the gene to the host plant such as the case of the plant pathogenic bacterium, Agrobacterium tumefaciens.
- An idealized vector would contain a multiple cloning site, an antibiotic resistance or other selective gene, a broad- host bacterial origin of replication, and a selection marker or gene for selection of the foreign DNA in transformed plants.
- constructs, promoters or control systems used in the methods of the invention may include a tissue specific promoter, an inducible promoter or a constitutive promoter.
- CaMV cauliflower mosaic virus 35S. It has been shown to be highly active in many plant organs and during many stages of development when integrated into the genome of transgenic plants including tobacco and petunia, and has been shown to confer expression in protoplasts of both dicots and monocots.
- Organ-specific promoters are also well known.
- the E8 promoter is only transcriptionally activated during tomato fruit ripening, and can be used to target gene expression in ripening tomato fruit (Deikman and Fischer, EMBO J. (1988) 7:3315; Giovannoni et al., The Plant Cell (1989) 1:53).
- the activity of the E8 promoter is not limited to tomato fruit, but is thought to be compatible with any system wherein ethylene activates biological processes.
- the Lipoxegenase (“the LOX gene") is a fruit specific promoter.
- Seed specific promoters include the Napin promoter described in united States Patent 5,110,728 to Calgene, which describes and discloses the use of the napin promoter in directing the expression to seed tissue of an acyl carrier protein to enhance seed oil production; the DC3 promoter from carrots which is early to mid embryo specific and is disclosed at Plant Physiology, Oct. 1992 100(2) p. 576-581, "Hormonal and Environmental Regulation of the Carrot Lea-class Gene Dc 3, and Plant Mol. Biol., April 1992, 18(6) p.
- phaseolin promoter described in United States Patent 5,504,200 to Mycogen which discloses the gene sequence and regulatory regions for phaseolin, a protein isolated from P. vulgaris which is expressed only while the seed is developing within the pod, and only in tissues involved in seed generation.
- organ-specific promoters appropriate for a desired target organ can be isolated using known procedures. These control sequences are generally associated with genes uniquely expressed in the desired organ. In a typical higher plant, each organ has thousands of mRNAs that are absent from other organ systems (reviewed in Goldberg, Phil, Trans. R. Soc. London (1986) B314-343. mRNAs are first isolated to obtain suitable probes for retrieval of the appropriate genomic sequence which retains the presence of the natively associated control sequences. An example of the use of techniques to obtain the cDNA associated with mRNA specific to avocado fruit is found in Christoffersen et al., Plant Molecular Biology (1984) 3:385. Briefly, mRNA was isolated from ripening avocado fruit and used to make a cDNA library.
- Clones in the library were identified that hybridized with labeled RNA isolated from ripening avocado fruit, but that did not hybridize with labeled RNAs isolated from unripe avocado fruit. Many of these clones represent mRNAs encoded by genes that are transcriptionally activated at the onset of avocado fruit ripening.
- the promoter used in the method of the invention may also be an inducible promoter.
- An inducible promoter is a promoter that is capable of directly or indirectly activating transcription of a DNA sequence in response to an inducer. In the absence of an inducer, the DNA sequence will not be transcribed.
- the protein factor that binds specifically to an inducible promoter to activate transcription is present in an inactive form which is then directly or indirectly converted to the active form by the inducer.
- the inducer may be a chemical agent such as a protein, metabolite (sugar, alcohol etc.), a growth regulator, herbicide, or a phenolic compound or a physiological stress imposed directly by heat, salt, toxic elements etc.
- a plant cell containing an inducible promoter may be exposed to an inducer by externally applying the inducer to the cell such as by spraying, watering, heating, or similar methods.
- inducible promoters include the inducible 70 kd heat shock promoter of D. melanogaster (Freeling, M., Bennet, D.C., Maize ADN 1, Ann. Rev, of Genetics, 19:297-323) and the alcohol dehydrogenase promoter which is induced by ethanol (Nagao, R.T., et al., Miflin, B.J., Ed. Oxford Surveys of Plant Molecular and Cell Biology, Vol. 3, p.
- the inducible promoter may be in an induced state throughout seed formation or at least for a period which corresponds to the transcription of the DNA sequence of the recombinant DNA molecule(s).
- Another example of an inducible promoter is the chemically inducible gene promoter sequence isolated from a 27 kd subunit of the maize glutathione-S-transferase (GST II) gene.
- a number of other potential inducers may be used with this promoter as described in published PCT Application No. PCT/GB90/00110 by ICI.
- inducible promoter is the light inducible chlorophyll a/b binding protein (CAB) promoter, also described in published PCT Application No. PCT/GB90/00110 by ICI.
- CAB chlorophyll a/b binding protein
- inducible promoters have also been described in published Application No. EP89/103888.7 by Ciba-Geigy.
- PR protein genes especially the tobacco PR protein genes, such as PR-la, PR- lb, PR-lc, PR-1, PR-A, PR-S, the cucumber chitinase gene, and the acidic and basic tobacco beta-l,3-glucanase genes.
- inducers for these promoters as described in Application No. EP89/103888.7.
- the preferred promoters may be used in conjunction with naturally occurring flanking coding or transcribed sequences of the seed specific Polycomb genes or with any other coding or transcribed sequence that is critical to Polycomb formation and/or function.
- intron sequences may also be desirable to include some intron sequences in the promoter constructs since the inclusion of intron sequences in the coding region may result in enhanced expression and specificity.
- regions of one promoter may be joined to regions from a different promoter in order to obtain the desired promoter activity resulting in a chimeric promoter.
- Synthetic promoters which regulate gene expression may also be used.
- the expression system may be further optimized by employing supplemental elements such as transcription terminators and/or enhancer elements.
- an expression cassette or construct should also contain a transcription termination region downstream of the structural gene to provide for efficient termination.
- the termination region or polyadenylation signal may be obtained from the same gene as the promoter sequence or may be obtained from different genes.
- Polyadenylation sequences include, but are not limited to the Agrobacterium octopine synthase signal (Gielen et al., EMBO J. (1984) 3:835-846) or the nopaline synthase signal (Depicker et al., Mol. and Appl. Genet. (1982) 1:561-573). MARKER GENES
- Recombinant DNA molecules containing any of the DNA sequences and promoters described herein may additionally contain selection marker genes which encode a selection gene product which confer on a plant cell resistance to a chemical agent or physiological stress, or confers a distinguishable phenotypic characteristic to the cells such that plant cells transformed with the recombinant DNA molecule may be easily selected using a selective agent.
- selection marker gene is neomycin phosphotransferase (NPT II) which confers resistance to kanamycin and the antibiotic G-418.
- Cells transformed with this selection marker gene may be selected for by assaying for the presence in vitro of phosphorylation of kanamycin using techniques described in the literature or by testing for the presence of the mRNA coding for the NPT II gene by Northern blot analysis in RNA from the tissue of the transformed plant. Polymerase chain reactions are also used to identify the presence of a transgene or expression using reverse transcriptase PCR amplification to monitor expression and PCR on genomic DNA. Other commonly used selection markers include the ampicillin resistance gene, the tetracycline resistance and the hygromycin resistance gene. Transformed plant cells thus selected can be induced to differentiate into plant structures which will eventually yield whole plants. It is to be understood that a selection marker gene may also be native to a plant. TRANSFORMATION
- Agrobacterium tumefaciens is the etiologic agent of crown gall.
- the wild type form of Agrobacterium tumefaciens carries the Ti (tumor-inducing) plasmid that directs the production of tumorigenic crown gall growth on the host plants.
- the crown gall is produced following the transfer of the tumor inducing T-DNA region from the Ti plasmid into the genome of an infected plant. This DNA fragment encodes genes for auxin and cytokinin biosynthesis, and it is these hormones in high concentration that promote growth of undifferentiated cells in the crown gall.
- Transfer of the T-DNA to the plant genome requires that the Ti plasmid-encoded virulence genes as well as the T- DNA borders, a set of direct DNA repeats that delineate the region to be transferred.
- the tumor inducing genes can be removed from Ti plasmid vectors, disarming the pathogenic nature of the system, without affecting the transfer of DNA fragments between the T-DNA borders. Therefore, the tumor inducing genes are generally replaced with a gene encoding resistance to kanamycin, or some other gene, to allow for selection of transformants, and a gene encoding the desired trait.
- the Agrobacterium containing the engineered plasmid is co-cultivated with cultured plant cells or wounded tissue. The de- differentiated plant cells are then propagated on selective media, and a transgenic plant is subsequently regenerated from the transformed cells by altering the levels of auxin and cytokinin in the growth medium.
- Agrobacterium mediated transformation often employ binary vector systems, which divide the Ti plasmid into two components, a shuttle vector and a helper plasmid.
- the helper plasmid which is permanently placed in the Agrobacterium host, carries the virulence genes.
- a much smaller shuttle vector contains T-DNA borders, a broad-host range bacterial origin of replication, antibiotic resistance markers, and a multiple cloning site for incorporation of the foreign gene.
- a similar strategy employs cointegrating Ti plasmid vectors, whereby an intermediate plasmid containing antibiotic resistance, the gene to be transferred and one T-DNA border are used to transform A.
- tumefaciens containing a disarmed Ti plasmid possessing the virulence genes and one T- DNA border.
- the two plasmids homologously recombined in vivo at the T- DNA borders placing the antibiotic resistance gene and the gene of interest between two T-DNA borders, one from each plasmid.
- the genes are then transferred into plant tissue upon co-cultivation.
- the Agrobacterium system has been well studied and has further been developed into a system which permits routine transformation of a variety of plant tissues.
- Some of the tissues transformed utilizing Agrobacterium include tobacco, Barton, K.A. et al., Cell, 32:1033 (1983); tomato, Fillatti, J. et al., Bio/Technology, 5:726 (1987); sunflower, Everett, N. P. et al., Bio/Technology, 5:1201 (1987); cotton, Umbeck, P.
- Agrobacterium rhizogenes Another vector for biological plant transformation is Agrobacterium rhizogenes.
- A. rhizogenes which incite root formation in many dicotyledonous plant species, carries the Ri (root-inducing) plasmid which functions in a manner analogous to the Ti plasmid of A. tumefaciens. Transformation using A. rhizogenes has also been successfully utilized to transform plants, for example, alfalfa, Sukhapinda, K. et al, Plant Mol. Biol.. 8:209 (1987); Solanum nigrum L., Wei Z-H. et al., Plant Cell Reports 5:93 (1986); and, poplar, Pythoud, et al., supra.
- Electroporation is another effective means of introducing foreign DNA into plant cells.
- This technique involves transferring naked DNA into cells utilizing electrophoretic means. Since any DNA fragment can be delivered to the cell, this technique has the advantage of allowing assimilation of a gene without having to clone the DNA into a host vector such as A. tumefaciens.
- DNA viruses have been used as gene vectors. Both Cauliflower Mosaic Virus (CaMV) and the closely related Figwort Virus are circular duplex DNA viruses which replicate via transcription of a full-length (35S) genomic RNA intermediate. A cauliflower mosaic virus carrying a modified bacterial methotrexate-resistance gene was used to infect a plant, whereby the foreign gene was systemically spread in the plant.
- CaMV Cauliflower Mosaic Virus
- Figwort Virus DNA viruses
- a cauliflower mosaic virus carrying a modified bacterial methotrexate-resistance gene was used to infect a plant, whereby the foreign gene was systemically spread in the plant.
- Exogenous DNA can be introduced into cells or protoplasts by microinjection.
- Microinjection is a method where a solution of plasmid DNA is injected directly into the cell with a finely pulled glass needle. Alfalfa protoplasts have been transformed utilizing this method with a variety of plasmids. Reich, T.J. et al., Bio/Technology 4:1001 (1986).
- liposome fusion protoplasts and liposomees carrying the foreign gene of interest are brought together. As membranes merge, the foreign gene is transferred to the protoplast.
- Deshayes, A. et al. "Liposome-Mediated Transformation of Tobacco Mesophyl Protoplasts by an Escherichia coli Plasmid," EMBO J. 4:2731 (1985).
- a form of chemical mediated transformation utilizes polyethylene glycol (PEG) and has been carried out in N. tabacum a dicot, and Lolium multiflorum, a monocot. It is a chemical procedure of direct gene transfer based on synergistic interaction between Mg 2+ , PEG, and possibly Ca 2+ . ⁇ egrutiu, R. et al., Plant Mol. Biol.. 8:363 (1987).
- plants can be regenerated from tissue transformed with A. tumefaciens.
- tissue transformed with A. tumefaciens include sunflower, Everatt, ⁇ .P. et al., supra; tomato, Fillatti, J.J. et al., supra; white clover, White, D.W. R. et al., Plant Mol. biol. 8:461 (1987); canola (rapeseed), Pua, E-C, et al., supra; cotton, Umbeck, P. et al., supra; tobacco, Horsch, R.B. et al., Science 225:1229 (1985) and Hererra- Estrella, L. et al., Nature.
- Plant regeneration from protoplasts is a particularly useful technique. See Evans, D.A. et al., Handbook of Plant Cell Culture. 1:124 (1983). When a plant species can be regenerated from protoplasts, then direct gene transfer procedures can be utilized, and transformation is not dependent on the use of A. tumefaciens. Regeneration of plants from protoplasts has been demonstrated for rice, Abdullah, R. et al., Bio/Technology 4:1087 (1987); tobacco, Potrykus, I. et al., supra; canola, Kansha, et al., Plant Cell Reports 5:101 (1986); potato, Tavazza, R. et al., Plant Cell Reports 5:243 (1986); eggplant, Sihackaki, D.
- the organohydrolase may be harvested from the plant or the plant itself may be used to detoxify sites contaminated by organophosphorous neurotoxins, from insecticides, pesticides or even for use in chemical warfare detoxification.
- the expression cassette After the expression cassette is stably incorporated into regenerated transgenic plants, it can be transferred to other plants by sexual crossing. Any of a number of standard breeding techniques can be used, depending upon the species to be crossed.
- plants may be self-fertilized, leading to the production of a mixture of seed that consists of, in the simplest case, three types, homozygous (25%), heterozygous (50%) and null (25%) for the inserted gene.
- homozygous 25%
- heterozygous 50%)
- null 25%)
- Transgenic homozygous parental lines make possible the production of hybrid plants and seeds which will contain a modified protein component.
- Transgenic homozygous parental lines are maintained with each parent containing either the first or second recombinant DNA sequence operably linked to a promoter. Also incorporated in this scheme are the advantages of growing a hybrid crop, including the combining of more valuable traits and hybrid vigor.
- an OPH gene was created. This was accomplished by analyzing the amino acid sequence of OPH using the program BACKTRANSLATE (Wisconsin package version 9.1, Genetics Computer Group(GCG), Madison, Wisconsin) into a DNA coding sequence using a maize codon preference table tabulated from highly expressed maize genes (http://www.gcg.com/techsupport/data/maize-high.cod). The optimized sequence was then searched for putative deleterious sequences compiled in Table 1 using the GCG program FINDPATTERNS.
- Alternative codons were chosen to eliminate the deleterious mRNA signals in the DNA coding sequence and to add convenient restriction enzyme sites to facilitate downstream cloning. Codons that reflected less than 20% usage were avoided.
- the optimized DNA coding sequence was divided into a convenient cloning length of less than 350 base pairs.
- Each of the fragments was divided up into oligonucleotides of approximately 50 bases in length with 10 base overhangs. Oligonucleotides corresponding to both the sense and antisense strand were synthesized using a commercial supplier and all oligonucleotides were 5' phosphorylated. The oligonucleotides were diluted to 100 pmol/ ⁇ l and 1 nanomole of each oligonucleotide in each respective fragment was added to a microfuge tube and brought to 100 ⁇ l using water. The oligonucleotides were annealed by heating to 95°C and allowed to cool slowly to 4°C over a period of two hours.
- oligonucleotides were ligated at 16°C for one hour. Following the ligation, 1 ⁇ l and successive 1/10 dilutions were subjected to PCR using primers specific to the 5' and 3' ends of each fragment. The PCR reactions were then purified by polyacrylimide gel electrophoresis. The band corresponding to the correct size of each fragment was excised, and the DNA eluted from the gel slice using proceduresknown to those of skill in the art.
- the eluted DNA was cloned into the pCR2.1-TOPO (Invitrogen) as per the manufacturer's directions. Colonies containing the PCR insert were grown overnight, the plasmid DNA extracted and purified, and the plasmid DNA analyzed for the correct PCR insert as per standard protocols to those known of skill in the art. The inserts were sequenced to verify the correct sequence of each fragment and then the optimized gene was assembled (SEQ ID NO:l) using standard protocols known to those of skill in the art. The 5' fragment was assembled to contain a plant leader sequence (SEQ ID NO:2) to ensure high expression in plants and the OPH gene containing the plant leader (SEQ ID NO: 3) was cloned into a standard plant expression cassette to ensure high expression in plants.
- SEQ ID NO:2 plant leader sequence
- SEQ ID NO:3 was cloned into a standard plant expression cassette to ensure high expression in plants.
- Linearized or supercoiled plant vector DNA containing the OPH gene and plant leader sequence is mixed with the protoplasts in a final volume of 0.5 ml at a concentration of 0.1 mg/ml and 7 x 10 5 cells/ml respectively in a 16 mm diameter Nunc Multidish well.
- a single pulse is administered at room temperature (23°C) in a Hoefer PG 101 ProGenetor electroporation unit using a PG120-2.5 electrode for 10 msec at 200 V. Electroporated protoplasts are kept stationary for 10 minutes prior to the addition of 1 ml of culture medium. Cells were subsequently diluted to a final concentration of 10 5 cells/ml. These cells may then be assayed for transient expression of the OPH gene after a period of 40-48 hours or depending on the DNA vector construct used, plated to generate callus tissues under appropriate selection, followed by regeneration to whole plants.
- Regen I promotes somatic embryo differentiation (See Abbe & Stein, "The Origin of the Shoot Apex in Maize; Embryogeny", N.J. Bot. 41:285, 293 (1954)).
- Regen II promotes embryo enlargement and maturation, and Regen III promotes germination.
- the tissue is incubated on each medium for approximately two weeks. The first two incubation steps are carried out in the dark at 28°C and the final incubation step is carried out under a 16:8-hour photo period with about 70 ⁇ E ⁇ r 2 sec 1 provided by cool-white fluorescent bulbs at about 25°C.
- the plates Upon completion of all three incubations, the plates are placed in a single layer on shelves in a lighted incubator and are sealed with 3-M Scotch Brand #394 mending tape.
- 3-M tape is preferred over either Parafilm or masking tape as it "breathes" better and helps reduce condensation problems.
- Small green shoots formed on Regen III in 100 x 25-mm petri plates are transferred to Regen III medium and 200 x 25- mm Pyrex tubes or Phytatrays to permit further plantlet development and root formation.
- the plants may be carefully removed from the medium, the root system washed thoroughly under running water, and the plants placed into a 2. 5" square pot containing Metromix 350 growing medium. Watering with the systemic fungicide benomyl (100 mg/1 Benlate) will reduce the risk of fungal contamination. It is critical to maintain the freshly transplanted plants in a high humidity environment for several days.
- Regeneration of plants from Type II callus is based upon allowing the embryoids on the surface of the Type II callus to mature and germinate. See Freeling & Walbot, The Maize Handbook (1994) at page 673-674. The procedure used is essentially that as described in Freeling & Walbot. The callus are first collected and weighed in petri plates. 1-2 grams fresh weight of soft, friable Type II callus containing numerous embryoids are evenly distributed over the surface of a 100 x 15-mm petri plate which contains 25 ml of regeneration medium.
- Regeneration medium consists of Murashige and Skoog (MS) basal salts, modified White's vitamins (0.2 g/1 glycine, and 0.5 g/1 of each of thiamine-HCl, pyridoxine-HCl, and nicotinic acid), supplemented with 6% sucrose, 0.1 g/1 myo-inositol, and 0.8% Bacto-ager (6SMS0D).
- MS Murashige and Skoog
- modified White's vitamins 0.2 g/1 glycine, and 0.5 g/1 of each of thiamine-HCl, pyridoxine-HCl, and nicotinic acid
- 6SMS0D Bacto-ager
- the plate should be examined for shoot formation from the calli.
- the calli and the shoot should then be transferred to fresh Bacto-ager plates for another two weeks.
- the callus without shoots can be left on the Bacto-ager for a longer period if the callus is slow in embryo development.
- Magenta GA-7 Magneticenta Corp., Chicago, IL
- Organophosphorous hydrolase that is produced by transformed maize plants containing the optimized OPH gene and plant leader sequence is purified by standard methods known to those in the art.
- the presence of the OPH protein can be detected utilizing protein purified from transformed plant tissues.
- the expression and stability of the OPH gene product can be assayed by allowing the OPH optimized gene product to come into association with the pesticide, neurotoxin, or compound containing phosphoryl-bonds. These compounds can then be analyzed to determine if the OPH gene product hydrolyzed the P-O, P-F, P-CN, and/or P-S phosphoryl-bonds.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU40689/99A AU4068999A (en) | 1998-04-15 | 1999-04-14 | Optimized nucleotide sequence encoding organophosphorous hydrolase and methods of use for same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8184698P | 1998-04-15 | 1998-04-15 | |
US60/081,846 | 1998-04-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999053037A2 true WO1999053037A2 (fr) | 1999-10-21 |
WO1999053037A3 WO1999053037A3 (fr) | 1999-12-09 |
Family
ID=22166780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/008202 WO1999053037A2 (fr) | 1998-04-15 | 1999-04-14 | Sequences optimisees de nucleosides codant pour des hydrolases organophosphorees, et leurs methodes d'utilisation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4068999A (fr) |
WO (1) | WO1999053037A2 (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001071014A3 (fr) * | 2000-03-17 | 2002-05-30 | Thompson Boyce Plant Res | Expression d'acetylcholinesterase de recombinaison humaine dans des plantes transgeniques |
WO2002092803A1 (fr) * | 2001-05-15 | 2002-11-21 | Commonwealth Scientific And Industrial Research Organisation | Phosphotriesterase issue d'agrobacterium radiobacter p230 |
US7060501B2 (en) * | 2002-12-03 | 2006-06-13 | Applied Biotechnology Institute | Methods for selecting and screening for plant cells transformed with a polynucleotide encoding an organophosphate hydrolase |
GB2430436A (en) * | 2002-09-09 | 2007-03-28 | C Steven Mcdaniel | Biological active coating components |
CN1330760C (zh) * | 2005-10-11 | 2007-08-08 | 中国农业科学院生物技术研究所 | 重组有机磷降解酶基因、其表达载体及重组有机磷降解酶的制备方法 |
CN102145218A (zh) * | 2010-11-24 | 2011-08-10 | 高旌 | 一种植物体中农药快速降解剂 |
EP2441834A1 (fr) * | 2007-10-01 | 2012-04-18 | Guild Associates, Inc. | Biocapteurs de levure différentiellement fluorescente pour la détection et la biodégradation d'agents chimiques |
US8388904B1 (en) | 2008-12-22 | 2013-03-05 | Reactive Surfaces, Ltd., Llp | Equipment decontamination system and method |
US9796990B2 (en) | 2011-07-20 | 2017-10-24 | Commonwealth Scientific And Industrial Research Organization | Enzymes for degrading organophosphates |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589386A (en) * | 1988-08-26 | 1996-12-31 | Serdar; Cuneyt M. | Hydrolysis of cholinesterase inhibitors using parathion hydrolase |
NZ230375A (en) * | 1988-09-09 | 1991-07-26 | Lubrizol Genetics Inc | Synthetic gene encoding b. thuringiensis insecticidal protein |
US5474925A (en) * | 1991-12-19 | 1995-12-12 | Agracetus, Inc. | Immobilized proteins in cotton fiber |
-
1999
- 1999-04-14 AU AU40689/99A patent/AU4068999A/en not_active Abandoned
- 1999-04-14 WO PCT/US1999/008202 patent/WO1999053037A2/fr active Application Filing
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001071014A3 (fr) * | 2000-03-17 | 2002-05-30 | Thompson Boyce Plant Res | Expression d'acetylcholinesterase de recombinaison humaine dans des plantes transgeniques |
US8293244B2 (en) | 2001-05-15 | 2012-10-23 | Commonwealth Scientific And Industrial Research Organisation | Phosphotriesterase from agrobacterium radiobacter p230 |
WO2002092803A1 (fr) * | 2001-05-15 | 2002-11-21 | Commonwealth Scientific And Industrial Research Organisation | Phosphotriesterase issue d'agrobacterium radiobacter p230 |
AU2002252842B2 (en) * | 2001-05-15 | 2006-08-31 | Commonwealth Scientific And Industrial Research Organisation | Phosphotriesterase from Agrobacterium radiobacter P230 |
US8557547B2 (en) | 2001-05-15 | 2013-10-15 | Commonwealth Scientific And Industrial Research Organisation | Phosphotriesterase from agrobacterium radiobacter P230 |
GB2430436B (en) * | 2002-09-09 | 2007-06-06 | C Steven Mcdaniel | Biological active coating components, coatings, and coated surfaces |
GB2430436A (en) * | 2002-09-09 | 2007-03-28 | C Steven Mcdaniel | Biological active coating components |
US10413769B2 (en) | 2002-09-09 | 2019-09-17 | Reactive Surfaces, Ltd., Llp | Paint having cell wall particulate material with a protective organophosphorus esterase |
US7060501B2 (en) * | 2002-12-03 | 2006-06-13 | Applied Biotechnology Institute | Methods for selecting and screening for plant cells transformed with a polynucleotide encoding an organophosphate hydrolase |
CN1330760C (zh) * | 2005-10-11 | 2007-08-08 | 中国农业科学院生物技术研究所 | 重组有机磷降解酶基因、其表达载体及重组有机磷降解酶的制备方法 |
EP2441834A1 (fr) * | 2007-10-01 | 2012-04-18 | Guild Associates, Inc. | Biocapteurs de levure différentiellement fluorescente pour la détection et la biodégradation d'agents chimiques |
US8927244B2 (en) | 2007-10-01 | 2015-01-06 | Guild Associates, Inc. | Organophosphorus hydrolase |
US8388904B1 (en) | 2008-12-22 | 2013-03-05 | Reactive Surfaces, Ltd., Llp | Equipment decontamination system and method |
CN102145218A (zh) * | 2010-11-24 | 2011-08-10 | 高旌 | 一种植物体中农药快速降解剂 |
US9796990B2 (en) | 2011-07-20 | 2017-10-24 | Commonwealth Scientific And Industrial Research Organization | Enzymes for degrading organophosphates |
Also Published As
Publication number | Publication date |
---|---|
AU4068999A (en) | 1999-11-01 |
WO1999053037A3 (fr) | 1999-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111886337B (zh) | 形态发生因子用于改善基因编辑的用途 | |
Mader et al. | Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element | |
Uwer et al. | Inactivation of a glycyl-tRNA synthetase leads to an arrest in plant embryo development | |
CA2106718C (fr) | Methodes d'obtention de semence hybride | |
AU718262B2 (en) | Methods and constructs for producing male sterile plants | |
EA031429B1 (ru) | Сконструированные посадочные площадки для направленного воздействия на ген в растениях | |
CN111433363B (zh) | 非生物胁迫耐性提高的植物和提高植物非生物胁迫耐性的多聚核苷酸及方法 | |
US20230313212A1 (en) | Plastid transformation by complementation of nuclear mutations | |
US20210139924A1 (en) | Genes and gene combinations for enhanced corn performance | |
Charity et al. | Consistent and stable expression of the npt II, uid A and bar genes in transgenic Pinus radiata after Agrobacterium tumefaciens-mediated transformation using nurse cultures | |
JP2002532114A (ja) | トランスジェニック植物およびその作出法 | |
US20240417703A1 (en) | Error prone dna polymerase for organelle mutation | |
WO1999053037A2 (fr) | Sequences optimisees de nucleosides codant pour des hydrolases organophosphorees, et leurs methodes d'utilisation | |
US6603064B1 (en) | Nuclear male sterile plants, method of producing same and methods to restore fertility | |
JP4603882B2 (ja) | 子孫への形質分配が制御されているトランスジェニック植物 | |
WO2019085962A1 (fr) | Plantes tolérantes au stress abiotique et polynucléotides pour améliorer le stress abiotique et procédés | |
US20060294619A1 (en) | Method for plant transformation based on thje pollination-fecundation pathway and the products thereof | |
CN113215186B (zh) | 光呼吸支路蛋白在调控植物性状中的应用 | |
JPH08506003A (ja) | クルーシファaccシンターゼおよびその利用 | |
US20080235824A1 (en) | Use of Esterase Genes as Selectable Markers for Transforming Plant Cells | |
CA3188488A1 (fr) | Plantes genetiquement modifiees qui presentent une augmentation du rendement en graines comprenant un premier gene contenant un domaine de fixation de la biotine (badc) homozygote pour un allele de type sauvage, un second gene badc homozygote pour un allele mutant, et des homologues des premier et second genes bad | |
WO2021016906A1 (fr) | Plantes tolérantes au stress abiotique et procédés | |
US20030018995A1 (en) | Plants with a modified flower and seed development | |
EP2423316B1 (fr) | Procédé pour déterminer la fréquence de la recombinaison meiotique dans les plantes | |
US7557265B2 (en) | Plant phytase genes and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |